Background
Background Antipsychotic drugs are Antipsychotic drugs are associated with sexual dysfunction butthe associated with sexual dysfunction butthe mechanisms are poorly understood. mechanisms are poorly understood.
Aims Aims To ascertain the frequency of
To ascertain the frequency of sexual dysfunction in patients taking sexual dysfunction in patients taking conventional antipsychotics and to conventional antipsychotics and to determine the possible underlying determine the possible underlying mechanisms. mechanisms.
Method Method Sexual dysfunction was
Sexual dysfunction was assessed in101patients receiving assessed in101patients receiving conventional antipsychotic medication, 57 conventional antipsychotic medication, 57 normal controls and 55 controls attending normal controls and 55 controls attending a sexual dysfunction clinic. a sexual dysfunction clinic.
Results

Results Sexual dysfunction occurred in
Sexual dysfunction occurred in 45% of patients taking antipsychotic 45% of patients taking antipsychotic medication,17% of normal controls and medication,17% of normal controls and 61% of controls attending a sexual 61% of controls attending a sexual dysfunction clinic. Sexual dysfunction was dysfunction clinic. Sexual dysfunction was associated with autonomic side-effects in associated with autonomic side-effects in normoprolactinaemic males, butthe normoprolactinaemic males, butthe presence of hyperprolactinaemia presence of hyperprolactinaemia overrode other causes of sexual overrode other causes of sexual dysfunction.For women, dysfunction. For women, hyperprolactinaemia was the main cause hyperprolactinaemia was the main cause of sexual dysfunction. of sexual dysfunction.
Conclusions Conclusions Conventional anti-
Conventional antipsychotic medications cause significant psychotic medications cause significant levels of sexual dysfunction.Clinicians levels of sexual dysfunction.Clinicians should routinely enquire about sexual should routinely enquire about sexual symptoms prior to the prescription of symptoms prior to the prescription of antipsychotics and on follow-up. antipsychotics and on follow-up.
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Antipsychotic drugs are thought to interfere Antipsychotic drugs are thought to interfere with sexual functioning but the underlying with sexual functioning but the underlying mechanisms are poorly understood. Those mechanisms are poorly understood. Those few studies that have been attempted confew studies that have been attempted consistently show an association between sistently show an association between neuroleptic treatment and sexual dysfuncneuroleptic treatment and sexual dysfunction. The prevalence of sexual dysfunction tion. The prevalence of sexual dysfunction in groups treated with neuroleptics is in groups treated with neuroleptics is thought to be 60% in men and 30-93% thought to be 60% in men and 30-93% in women, with thioridazine being one of in women, with thioridazine being one of the worst culprits (Shader & Grinspoon, the worst culprits (Shader & Grinspoon, 1967; Kotin 1967; Kotin et al et al, 1976; Ghadirian , 1976; Ghadirian et al et al, , 1982; Teusch 1982; Teusch et al et al, 1995) . In addition, , 1995). In addition, sexual dysfunction is worse in patients with sexual dysfunction is worse in patients with schizophrenia taking antipsychotic medischizophrenia taking antipsychotic medication compared with unmedicated patients cation compared with unmedicated patients (Blair & Simpson, 1966; Aizenberg (Blair & Simpson, 1966; Aizenberg et al et al, , 1995; Kockott & Pfeiffer, 1996) . In this 1995; Kockott & Pfeiffer, 1996) . In this study we attempted to quantify how many study we attempted to quantify how many patients taking conventional antipsychotic patients taking conventional antipsychotic medication complain of sexual dysfunction medication complain of sexual dysfunction and to ascertain what mechanisms might be and to ascertain what mechanisms might be responsible for any sexual dysfunction seen. responsible for any sexual dysfunction seen.
METHOD METHOD Assessment Assessment
The questionnaires currently available to The questionnaires currently available to assess sexual functioning tend to dwell on assess sexual functioning tend to dwell on psychological and relationship aspects of psychological and relationship aspects of sexual functioning and have not been sexual functioning and have not been designed for patients with severe mental designed for patients with severe mental illness. Most patients taking antipsychotic illness. Most patients taking antipsychotic medication have schizophrenia, an illness medication have schizophrenia, an illness that undermines an individual's ability to that undermines an individual's ability to relate to other people sexually or otherwise. relate to other people sexually or otherwise. In this study, we were particularly interIn this study, we were particularly interested in our subjects' ability to have a ested in our subjects' ability to have a physical sexual experience, whether they physical sexual experience, whether they were in a relationship or not. To this end, were in a relationship or not. To this end, a questionnaire was developed -a modified a questionnaire was developed -a modified version of that used by Burke version of that used by Burke et al et al (1994 Burke et al et al ( ). (1994 . Their investigation found that men with Their investigation found that men with schizophrenia were able to answer direct schizophrenia were able to answer direct questions regarding concrete aspects of questions regarding concrete aspects of sexual functioning and that there was a sexual functioning and that there was a significant correlation between score on significant correlation between score on the the questionnaire and measures of dopaquestionnaire and measures of dopamine blockade. We modified the questionmine blockade. We modified the questionnaire so that it had sub-scales for the naire so that it had sub-scales for the different areas of sexual function and different areas of sexual function and included questions for women. The included questions for women. The questionnaire asks about physical aspects questionnaire asks about physical aspects of sexual function so that it is not necessary of sexual function so that it is not necessary for the subject to have a partner in order to for the subject to have a partner in order to complete it. complete it.
The Sexual Functioning Questionnaire The Sexual Functioning Questionnaire (SFQ) that we developed (see Appendix) (SFQ) that we developed (see Appendix) asks detailed questions about libido, asks detailed questions about libido, physical arousal (erection in men, vaginal physical arousal (erection in men, vaginal lubrication in women), masturbation, lubrication in women), masturbation, orgasm (including dyspareunia) and ejacuorgasm (including dyspareunia) and ejaculation. It is designed such that higher scores lation. It is designed such that higher scores indicate greater dysfunction. It has good indicate greater dysfunction. It has good reliability: Cronbach's reliability: Cronbach's a a¼0.90; Guttman's 0.90; Guttman's split-half reliability split-half reliability¼0.86. 0.86.
As well as sexual function, the followAs well as sexual function, the following were collected in more detail for the ing were collected in more detail for the patient group: patient group: 
Subjects Subjects
The SFQ was administered to: a conseThe SFQ was administered to: a consecutive series of out-patient clinic attenders cutive series of out-patient clinic attenders stabilised on antipsychotic medication stabilised on antipsychotic medication ( (n n¼101); consecutive attenders at a general 101); consecutive attenders at a general practice clinic ( practice clinic (n n¼57) who acted as normal 57) who acted as normal controls (mainly presenting with minor controls (mainly presenting with minor respiratory infections); and patients attendrespiratory infections); and patients attending a hospital sexual dysfunction clinic ing a hospital sexual dysfunction clinic ( (n n¼55), who acted as ill controls (i.e. indi-55), who acted as ill controls (i.e. individuals with reported and recognised sexual viduals with reported and recognised sexual dysfunction). All the clinics are in the same dysfunction). All the clinics are in the same catchment area in South London, served by catchment area in South London, served by the Maudsley and King's College Hospitals. the Maudsley and King's College Hospitals.
Of the patients who were approached, Of the patients who were approached, 8 refused to enter the study and 36 were 8 refused to enter the study and 36 were excluded because of the reasons cited excluded because of the reasons cited below. below.
Subjects between the ages of 18 and 60 Subjects between the ages of 18 and 60 years stabilised on antipsychotic medication years stabilised on antipsychotic medication were eligible for entry into the study. were eligible for entry into the study.
Exclusion criteria included diabetes, hyperExclusion criteria included diabetes, hypertension, cardiovascular disease, gonadal tension, cardiovascular disease, gonadal injury, endocrine disorder/medication, injury, endocrine disorder/medication, alcohol misuse, antidepressant or antialcohol misuse, antidepressant or anticonvulsant medication, inability to give convulsant medication, inability to give consent or answer questions and female consent or answer questions and female patients who were peri-or post-menopausal. patients who were peri-or post-menopausal.
Analyses Analyses
Results were analysed using SPSS version Results were analysed using SPSS version 7.5 for Windows. The results for males 7.5 for Windows. The results for males and females were analysed separately and females were analysed separately because the design of the questionnaire is because the design of the questionnaire is such that there are different questions and such that there are different questions and thus different overall scores, depending on thus different overall scores, depending on gender. gender.
Demographic characteristics and outDemographic characteristics and outcome on the SFQ were evaluated for differcome on the SFQ were evaluated for differences across the three groups using one-way ences across the three groups using one-way analysis of variance (ANOVA) for conanalysis of variance (ANOVA) for continuous variables (with 95% CI for differtinuous variables (with 95% CI for difference in means) and chi-squared analysis ence in means) and chi-squared analysis for categorical variables. Relationships befor categorical variables. Relationships between different variables were assessed tween different variables were assessed with Pearson's correlation with Pearson's correlation coefficient and coefficient and partial correlations. Analysis partial correlations. Analysis of covariance of covariance (ANCOVA) was used to ascertain the effect (ANCOVA) was used to ascertain the effect of different variables on the SFQ score. The of different variables on the SFQ score. The Bonferroni test was used for Bonferroni test was used for post hoc post hoc analyanalysis of difference. To correct for the large sis of difference. To correct for the large number of statistical tests conducted in number of statistical tests conducted in the univariate analysis, the 1% level was the univariate analysis, the 1% level was used to look for significant effects rather used to look for significant effects rather than the 5% level. than the 5% level.
RESULTS RESULTS
Sexual dysfunction scores Sexual dysfunction scores
The mean score on the SFQ was 20.5 for The mean score on the SFQ was 20.5 for patients, 12.6 for normal controls and patients, 12.6 for normal controls and 21.5 for controls from the sexual dys-21.5 for controls from the sexual dysfunction clinic (the 95% CI for difference function clinic (the 95% CI for difference in means between patients and normal in means between patients and normal controls was 4.7-11.1). Table 1 shows the controls was 4.7-11.1). Table 1 shows the scores in each area of sexual function by scores in each area of sexual function by group.
group.
An arbitrary cut-off point of 1 standard An arbitrary cut-off point of 1 standard deviation above the mean was taken as the deviation above the mean was taken as the threshold above which sexual dysfunction threshold above which sexual dysfunction was said to be present. Using this threshold was said to be present. Using this threshold for normal controls, 45% of the subject for normal controls, 45% of the subject group reported sexual dysfunction comgroup reported sexual dysfunction compared with 17% of normal controls and pared with 17% of normal controls and 61% of controls from the sexual dys-61% of controls from the sexual dysfunction clinic. function clinic.
Patients taking antipsychotics reported Patients taking antipsychotics reported levels of libido that did not differ signifilevels of libido that did not differ significantly from that of normal controls. Using cantly from that of normal controls. Using the criterion stated above for sexual dysthe criterion stated above for sexual dysfunction, the male patients were 6.3 times function, the male patients were 6.3 times as likely to complain of sexual dysfunction as likely to complain of sexual dysfunction as the normal control males (95% CI 1.8-as the normal control males (95% CI 1.8-23.4), 3.7 times as likely to complain of 23.4), 3.7 times as likely to complain of erectile dysfunction (95% CI 1.4-10.1) erectile dysfunction (95% CI 1.4-10.1) and 16.4 times as likely to complain of and 16.4 times as likely to complain of ejaculatory dysfunction (95% CI 2.1-ejaculatory dysfunction (95% CI 2.1-128.5). 128.5). Female patients were 9.6 times more Female patients were 9.6 times more likely to complain of orgasmic dysfunction likely to complain of orgasmic dysfunction (95% CI 2.9-32.1) than the normal (95% CI 2.9-32.1) than the normal control females (95% CI 1.3-10.1). There control females (95% CI 1.3-10.1). There were no significant differences between were no significant differences between the level of sexual dysfunction reported by the level of sexual dysfunction reported by the patient group compared with those atthe patient group compared with those attending the sexual dysfunction clinic, tending the sexual dysfunction clinic, although the patient group tended to have although the patient group tended to have better levels of libido. It is of note that the better levels of libido. It is of note that the male patients described difficulty in achievmale patients described difficulty in achieving erections, including morning erections ing erections, including morning erections and complete inability to achieve erection and complete inability to achieve erection enough for penetration. Also, the male enough for penetration. Also, the male patients particularly complained of delayed patients particularly complained of delayed ejaculation or reduced ejaculatory volume. ejaculation or reduced ejaculatory volume. Subjects were asked about masturbatory Subjects were asked about masturbatory activity. Male patients reported as much activity. Male patients reported as much masturbatory activity as normal controls masturbatory activity as normal controls (odds ratio (odds ratio¼0.8 (0.7-1.1), NS) and 0.8 (0.7-1.1), NS) and controls from the sexual dysfunction clinic controls from the sexual dysfunction clinic (0.8 (0.7-0.9), NS). Female patients also (0.8 (0.7-0.9), NS). Female patients also reported similar levels of masturbatory reported similar levels of masturbatory activity compared with normal controls activity compared with normal controls (odds ratio (odds ratio¼0.7 (0.5-1.1), NS) and 0.7 (0.5-1.1), NS) and controls from the sexual dysfunction clinic controls from the sexual dysfunction clinic (0.6 (0.3-1.5), NS). (0.6 (0.3-1.5), NS).
Age and sexual function Age and sexual function
Age distributions of the three groups Age distributions of the three groups differed in both men and women, although differed in both men and women, although this did not reach significance for men this did not reach significance for men (Table 2 ). Age and sexual (Table 2 ). Age and sexual functioning are functioning are related such that as age increases, sexual related such that as age increases, sexual function may worsen. Controlling for age, function may worsen. Controlling for age, however, made little difference to the result however, made little difference to the result for males; patients taking antipsychotic for males; patients taking antipsychotic medication and controls attending the medication and controls attending the sexual dysfunction clinic still scored signifsexual dysfunction clinic still scored significantly higher on the SFQ. For females, icantly higher on the SFQ. For females, 5 0 5 0 2 show a breakdown of the scores on the SFQ for each medication the scores on the SFQ for each medication subtype in each area of sexual functioning subtype in each area of sexual functioning for men and women. There were no sigfor men and women. There were no significant differences between medication nificant differences between medication type and overall mean SFQ score, although type and overall mean SFQ score, although there was a tendency (in both men and there was a tendency (in both men and women) for those taking butyrophenones women) for those taking butyrophenones to report less sexual dysfunction than those to report less sexual dysfunction than those taking other drugs. When sexual function taking other drugs. When sexual function was broken down into its components, it was broken down into its components, it can be seen that medication type did not can be seen that medication type did not distinguish between male subjects with distinguish between male subjects with sexual dysfunction. However, for females, sexual dysfunction. However, for females, the substituted benzamides and thiothe substituted benzamides and thioxanthenes were more likely to be associated xanthenes were more likely to be associated with physical arousal problems than other with physical arousal problems than other drugs and the aliphatic phenothiazines drugs and the aliphatic phenothiazines and thioxanthenes were more likely to and thioxanthenes were more likely to cause anorgasmia than other drugs. This cause anorgasmia than other drugs. This finding was strengthened by controlling finding was strengthened by controlling for dose of medication. for dose of medication.
Factors associated with sexual Factors associated with sexual dysfunction dysfunction Table 3 shows mean depression scores, Table 3 shows mean depression scores, mean autonomic side-effect scores, mean mean autonomic side-effect scores, mean dose of medication (in chlorpromazine dose of medication (in chlorpromazine equivalents) and mean prolactin levels for equivalents) and mean prolactin levels for the patient group. Patients had mild to the patient group. Patients had mild to moderate levels of depression and moderate moderate levels of depression and moderate to high rates of autonomic side-effects. For to high rates of autonomic side-effects. For the male patients, prolactin levels were in the male patients, prolactin levels were in the high normal range, with 34% being the high normal range, with 34% being hyperprolactinaemic (prolactin hyperprolactinaemic (prolactin4 4480 IU/l).
480 IU/l). Female patients had mean prolactin levels Female patients had mean prolactin levels that were outside the normal range, with that were outside the normal range, with 51 51 P¼0.012) but there was no 0.012) but there was no association between depression and ejacuassociation between depression and ejaculatory function. Dose of medication was latory function. Dose of medication was significantly correlated with erectile dyssignificantly correlated with erectile dysfunction ( function (r r¼0.3, 0.3, P P¼0.02). Autonomic 0.02). Autonomic side-effects were significantly correlated side-effects were significantly correlated with male sexual dysfunction, such that with male sexual dysfunction, such that anticholineric side-effects were particularly anticholineric side-effects were particularly associated with erectile dysfunction associated with erectile dysfunction ( (r r¼0.32, 0.32, P P¼0.041) and antiadrenergic 0.041) and antiadrenergic side-effects were associated with abnormal side-effects were associated with abnormal ejaculation (retarded ejaculation or reduced ejaculation (retarded ejaculation or reduced volume) ( volume) (r r¼0.43, 0.43, P P¼0.006). Controlling 0.006). Controlling for dose of medication resulted in these for dose of medication resulted in these relationships being strengthened ( relationships being strengthened (r r¼0.43, 0.43, P P¼0.006 for erectile dysfunction; 0.006 for erectile dysfunction; r r¼0.53, 0.53, P P5 50.001 for ejaculatory function). For 0.001 for ejaculatory function). For male patients there was no correlation male patients there was no correlation between prolactin and any measure of between prolactin and any measure of sexual dysfunction. sexual dysfunction.
Thirty-four per cent of the males were Thirty-four per cent of the males were hyperprolactinaemic. For this group, the hyperprolactinaemic. For this group, the overall reported sexual dysfunction did overall reported sexual dysfunction did not differ from the normoprolactinaemic not differ from the normoprolactinaemic male patients. However, when sexual male patients. However, when sexual function was broken down into its compofunction was broken down into its component areas, age, depression and autonomic nent areas, age, depression and autonomic side-effects ceased to be related to measures side-effects ceased to be related to measures of sexual dysfunction, whereas prolactin of sexual dysfunction, whereas prolactin was negatively associated with erectile was negatively associated with erectile dysfunction ( dysfunction (r r¼7 70.562, 0.562, P P¼0.023) and 0.023) and quality of orgasm ( quality of orgasm (r r¼7 70.56, 0.56, P P¼0.023). 0.023). For female patients there was no correFor female patients there was no correlation between age and sexual dysfunction lation between age and sexual dysfunction or autonomic side-effects and sexual or autonomic side-effects and sexual dysfunction. Dose of medication was dysfunction. Dose of medication was associated with reduced physical arousal associated with reduced physical arousal ( (r r¼0.36, 0.36, P P¼0.05). Depression was signifi-0.05). Depression was significantly correlated with poor libido cantly correlated with poor libido ( (r r¼0.41, 0.41, P P¼0.03), reduced physical arousal 0.03), reduced physical arousal ( (r r¼0.59, 0.59, P P¼0.001) and orgasmic problems 0.001) and orgasmic problems ( (r r¼0.648, 0.648, P P5 50.001). Prolactin correlated 0.001). Prolactin correlated negatively with libido ( negatively with libido (r r¼7 70.46, 0.46, P P¼0.03) 0.03) and physical arousal problems such as poor and physical arousal problems such as poor vaginal response ( vaginal response (r r¼0.52, 0.52, P P¼0.02). Con-0.02). Controlling for dose of medication reduced trolling for dose of medication reduced the significance of the association between the significance of the association between prolactin and libido ( prolactin and libido (r r¼7 70.46, 0.46, P P¼0.06), 0.06), as did controlling for depression as did controlling for depression ( (r r¼7 70.37, 0.37, P P¼0.17). However, the associa-0.17). However, the association between prolactin and poor vaginal tion between prolactin and poor vaginal response was strengthened by controlling response was strengthened by controlling for dose of medication ( for dose of medication (r r¼0.6, 0.6, P P¼0.011) 0.011) and for depression ( and for depression (r r¼0.62, 0.62, P P¼0.014). 0.014).
DISCUSSION DISCUSSION
Methodology Methodology
Our questionnaire did not address aspects Our questionnaire did not address aspects of relationships and it may be that it is of relationships and it may be that it is not complete to discuss sexual function outnot complete to discuss sexual function outside the context of a relationship. However, side the context of a relationship. However, the majority of patients in this study did not the majority of patients in this study did not have partners (88.5% never married, have partners (88.5% never married, separated or divorced, with 71.3% not separated or divorced, with 71.3% not married or co-habiting). This compares married or co-habiting). This compares with a British population figure of 29.1% with a British population figure of 29.1% for a similarly aged group who are without for a similarly aged group who are without partners (Office for National Statistics, partners (Office for National Statistics, 1999) . A questionnaire that included 1999). A questionnaire that included questions about relationships with other questions about relationships with other people would have resulted in the majority people would have resulted in the majority of the patients being unable to enter the of the patients being unable to enter the study. study.
The best way of finding out whether The best way of finding out whether antipsychotic medication has a negative antipsychotic medication has a negative effect on sexual function is to compare effect on sexual function is to compare subjects before and after they start medisubjects before and after they start medication. We found that many patients who cation. We found that many patients who were drug-free were too unwell to complete were drug-free were too unwell to complete a questionnaire asking intimate details a questionnaire asking intimate details about sexual function. The design of this about sexual function. The design of this present study still allows for us to estimate present study still allows for us to estimate the level of sexual dysfunction and also the level of sexual dysfunction and also allows us to tease out the mechanisms that allows us to tease out the mechanisms that might be underlying any sexual dysfunction might be underlying any sexual dysfunction seen in patients taking antipsychotic seen in patients taking antipsychotic medication. medication.
Although there were sufficient numbers Although there were sufficient numbers to give 99% power to distinguish between to give 99% power to distinguish between the groups in terms of sexual function, the the groups in terms of sexual function, the study was only partly able to ascertain study was only partly able to ascertain the effect of different neuroleptics on the the effect of different neuroleptics on the individual areas of sexual function because individual areas of sexual function because of the small numbers of patients taking of the small numbers of patients taking certain drug types. certain drug types.
Sexual function Sexual function
Patients taking antipsychotics reported high Patients taking antipsychotics reported high levels of sexual dysfunction, similar to the levels of sexual dysfunction, similar to the levels seen in a sexual dysfunction clinic, levels seen in a sexual dysfunction clinic, yet these patients were no more likely to yet these patients were no more likely to have abnormal sexual interest or to masturhave abnormal sexual interest or to masturbate than normal controls. This appears to bate than normal controls. This appears to counter the commonly held view that psycounter the commonly held view that psychotic illness chotic illness ipso facto ipso facto leads to abnormal leads to abnormal sexual interest. However, our finding of sexual interest. However, our finding of normal libido may be in keeping with normal libido may be in keeping with Aizenberg Aizenberg et al et al 's (1995) view that anti-'s (1995) view that antipsychotic medication has a positive effect psychotic medication has a positive effect on psychological functioning and thus on psychological functioning and thus allows patients with schizophrenia to have allows patients with schizophrenia to have normal sexual interest. normal sexual interest.
Mechanisms underlying sexual Mechanisms underlying sexual dysfunction in patients taking dysfunction in patients taking antipsychotic drugs antipsychotic drugs
For men, we found that increasing age, For men, we found that increasing age, higher levels of depression, higher doses of higher levels of depression, higher doses of medication or worse anticholinergic or medication or worse anticholinergic or antiadrenergic side-effects were all antiadrenergic side-effects were all associated with higher levels of reported associated with higher levels of reported sexual dysfunction. These relationships sexual dysfunction. These relationships ceased to exist when men were hyperceased to exist when men were hyperprolactinaemic. This indicates that treatprolactinaemic. This indicates that treatment-emergent sexual dysfunction is most ment-emergent sexual dysfunction is most commonly associated with the autonomic commonly associated with the autonomic side-effects of antipsychotic drugs, but, side-effects of antipsychotic drugs, but, if a man becomes hyperprolactinaemic if a man becomes hyperprolactinaemic following antipsychotic treatment, this following antipsychotic treatment, this raised prolactin is likely to be the main raised prolactin is likely to be the main cause of any sexual dysfunction seen. cause of any sexual dysfunction seen. The majority of women in our study The majority of women in our study were hyperprolactinaemic, they complained were hyperprolactinaemic, they complained of high rates of sexual dysfunction and this of high rates of sexual dysfunction and this was significantly related to their levels of was significantly related to their levels of depression, dose of medication or their depression, dose of medication or their prolactin level but not to other factors such prolactin level but not to other factors such as age or autonomic side-effects. When as age or autonomic side-effects. When depression and dose of medication were depression and dose of medication were controlled, the relationship between procontrolled, the relationship between prolactin and sexual dysfunction in females lactin and sexual dysfunction in females strengthened, implying that hyperprostrengthened, implying that hyperprolactinaemia is the main cause of sexual lactinaemia is the main cause of sexual dysfunction in females taking antipsychotic dysfunction in females taking antipsychotic medication. medication.
For men, we were unable to differFor men, we were unable to differentiate between medications in terms of entiate between medications in terms of sexual dysfunction. In women, substituted sexual dysfunction. In women, substituted benzamides (e.g. sulpiride) and thiobenzamides (e.g. sulpiride) and thioxanthenes (e.g. flupentixol decanoate) were xanthenes (e.g. flupentixol decanoate) were more likely to be associated with physical more likely to be associated with physical arousal problems than other medications, arousal problems than other medications, whereas aliphatic phenothiazines (e.g. whereas aliphatic phenothiazines (e.g. chlorpromazine) and thioxanthenes were chlorpromazine) and thioxanthenes were more likely to be associated with more likely to be associated with anorgasmia. anorgasmia.
Sulpiride is a highly selective dopamine Sulpiride is a highly selective dopamine blocker; flupentixol, in common with other blocker; flupentixol, in common with other thioxanthenes, is a potent inhibitor at the thioxanthenes, is a potent inhibitor at the dopamine receptor and has few anticholidopamine receptor and has few anticholinergic or antiadrenergic effects. Difficulty nergic or antiadrenergic effects. Difficulty with physical arousal (e.g. poor vaginal with physical arousal (e.g. poor vaginal lubrication, as seen in postmenopausal lubrication, as seen in postmenopausal women) is thought to be a result of hypowomen) is thought to be a result of hypooestrogenaemia and is a common finding oestrogenaemia and is a common finding in patients with hyper in patients with hyperprolactinaemia (Bachprolactinaemia (Bachmann, 1995; Schlechte, mann, 1995; Schlechte, 1995) . The fact that 1995). The fact that the women taking substituted benzamides the women taking substituted benzamides and thioxanthenes were suffering the sexual and thioxanthenes were suffering the sexual side-effects commonly seen with hyperproside-effects commonly seen with hyperprolactinaemia reinforces our finding that this lactinaemia reinforces our finding that this is the main cause of sexual dysfunction in is the main cause of sexual dysfunction in the women taking antipsychotic medication the women taking antipsychotic medication in this study. in this study.
Sexual dysfunction and compliance Sexual dysfunction and compliance
Non-adherence to antipsychotic medication Non-adherence to antipsychotic medication is one of the main causes of relapse in is one of the main causes of relapse in patients with psychotic illness. Side-effects patients with psychotic illness. Side-effects of medication are frequently cited as a of medication are frequently cited as a reason for non-compliance. Clinicians reason for non-compliance. Clinicians generally feel that the worse side-effects of generally feel that the worse side-effects of antipsychotic medication are the extraantipsychotic medication are the extrapyramidal side-effects and those most likely pyramidal side-effects and those most likely to trouble patients and make it difficult for to trouble patients and make it difficult for the person to adhere to their medication the person to adhere to their medication regime (Smith & Henderson, 2000) . regime (Smith & Henderson, 2000) . Despite this, Finn Despite this, Finn et al et al (1990) showed that (1990) showed that patients are more concerned with the patients are more concerned with the sexual side-effects of their medications than sexual side-effects of their medications than any other side-effect. The National Schizoany other side-effect. The National Schizophrenia Fellowship have published a survey phrenia Fellowship have published a survey of over 2000 mental health service users of over 2000 mental health service users (http://www.nsf.org.uk/information/research). (http://www.nsf.org.uk/information/research). They found that a large proportion of the They found that a large proportion of the people had experienced side-effects from people had experienced side-effects from their antipsychotic medication and that their antipsychotic medication and that sexual side-effects were deemed to be the sexual side-effects were deemed to be the most troublesome. most troublesome.
Clearly, sexual side-effects of mediClearly, sexual side-effects of medication may be an important cause of noncation may be an important cause of nonadherence. The findings from this study adherence. The findings from this study give an indication of how this troublesome give an indication of how this troublesome side-effect may be combated. side-effect may be combated. for their cooperation during the course of this study. 
Each statement is followed by a TRUE or FALSE answer. Read each statement carefully and decide which response best describes how you feel. Then put a circle Each statement is followed by a TRUE or FALSE answer. Read each statement carefully and decide which response best describes how you feel. Then put a circle round the corresponding response. If you are not completely sure which response is more accurate, circle the response that you feel is most appropriate. Please round the corresponding response. If you are not completely sure which response is more accurate, circle the response that you feel is most appropriate. Antipsychotics with fewer effects on prolactin may be less likely to cause sexual dysfunction, especially in women, and therefore these drugs should be used dysfunction, especially in women, and therefore these drugs should be used preferentially to avoid sexual difficulties. preferentially to avoid sexual difficulties.
LIMITATIONS LIMITATIONS
& & We did not include unmedicated patients in the study.
We did not include unmedicated patients in the study. 
